Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer
To explore the signature function of the tumor mutational burden (TMB) and potential biomarkers in prostate cancer (PCa), transcriptome profiles, somatic mutation data, and clinicopathologic feature information were downloaded from The Cancer Genome Atlas (TCGA) database. R software package was used...
Guardado en:
Autores principales: | Licheng Wang MM, Yicong Yao MM, Chengdang Xu MM, Xinan Wang MM, Denglong Wu MD, PhD, Zhe Hong MD, PhD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1475b158b2494224bfbaa17f3c4d00ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
por: Hongsik Kim MD, et al.
Publicado: (2021) -
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
por: Wen-lan Dong, MD, et al.
Publicado: (2021) -
TACE Combined with HIFU Versus
Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study
por: Qiwei Zhang MM, et al.
Publicado: (2021) -
Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia
por: Cunte Chen MD, et al.
Publicado: (2021) -
Contrast-enhanced Ultrasound for Diagnosing Pancreatic Solitary Fibrous Tumor: A Case Report
por: Lei Chen, MM, Cong Chen, MM, Qingfu Qian, MM, Zhikui Chen, PhD
Publicado: (2021)